药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Alphameprodine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Gilteritinib.
Alphameprodine
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Gilteritinib.
Alphameprodine
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Gilteritinib.
Alphameprodine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Gilteritinib.
Alphameprodine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Gilteritinib.
Alphameprodine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Gilteritinib.
Alphameprodine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Gilteritinib.
Alphameprodine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Gilteritinib.
Alphameprodine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Gilteritinib.
Alphameprodine
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Gilteritinib.
Alphameprodine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Gilteritinib.
Alphameprodine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Gilteritinib.
Alphameprodine
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gilteritinib.
Alphameprodine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Gilteritinib.
Alphameprodine
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Gilteritinib.
Alphameprodine
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Gilteritinib.
Alphameprodine
Celiprolol
The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Gilteritinib.
Alphameprodine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Gilteritinib.
Alphameprodine
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Gilteritinib.
Alphameprodine
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Gilteritinib.